As the population of older adults grows and the wider clinical acceptance of therapies increases, the adoption rate is speeding up
This is particularly crucial during weight loss, where the objective is to lose fat while preserving muscle, she explains
Available GLP-1 drugs At this time, for the purposes of the Medicare GLP-1 Bridge, an eligible GLP-1 drug is any of the following products when used to reduce excess body weight and maintain weight reduction: Foundayo Wegovy (injection and tablets) Zepbound (KwikPen formulation only) This list may be updated over the course of the program
Triple-Action Structure With Added Glucagon Retatrutide is a triple-action therapy that, like Lillys Mounjaro and Zepbound drugs, targets glucagon-like peptide-1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP, while also acting on the glucagon receptor
verify current information from official sources before travel
Ongoing progress monitoring: Regular check-ins allow adjustments based on your response